
Merck has announced that it has invested €35m in biosafety testing at its sites in Glasgow and Stirling, both Scotland. …
Aiforia deal to expand access to pathology AI
SMC accepts atogepant for acute migraine treatment in Scotland
New CCO Ogburn joins Cori Clinical

